230.01 USD
-1.79
0.77%
At close Updated Nov 28, 4:00 PM EST
Pre-market
After hours
222.94
-7.07
3.07%
1 day
-0.77%
5 days
5.81%
1 month
5.45%
3 months
21.87%
6 months
65.74%
Year to date
17.88%
1 year
14.52%
5 years
36.11%
10 years
238.3%
 

About: Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Employees: 91,000

0
Funds holding %
of 7,476 funds
0
Analysts bullish %
of 12 analysts
0
Positive news %
of 6 articles
Price charts implemented using Lightweight Charts™